Trial on the Efficacy of Tegaderm Chlorhexidine Gluconate (CHG) in Reducing Catheter Related Bloodstream Infections

Exclusion Criteria

• •Age \< 18 years
• •Inability to obtain an informed consent
• •Actual evidence - or recent history (\< 30 days) - of bloodstream infection
• •Central lines inserted in the femoral vein
• •Central lines inserted by surgical cutdown
• •Use of so called 'treated' catheters, i.e. catheters whose internal and/or external surface is coated with antibacterial drugs as well as catheters whose polyurethane releases ions with potential antiseptic action, should be excluded by the present protocol
• •Specific intolerance or known hypersensitivity to transparent dressings or to chlorhexidine
• •Any form of dermatitis, burns, skin lesions or tattoos at the insertion site
• •Burns over ≥ 15% of the body surface area
• •Use of topical antibiotics within a 10cm of the catheter insertion site
• •Enrollment in another investigational drug or device study at any time during this study or 30 days prior.